{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol&page=4", "query": { "intervention": "Alcohol", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 4411, "total_pages": 442, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T22:49:44.457Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01464359", "title": "T-Cell Depleted Double UCB for Refractory AML", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myelogenous Leukemia", "Refractory Acute Myelogenous Leukemia" ], "interventions": [ { "name": "Allopurinol", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Total body irradiation", "type": "RADIATION" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Levetiracetam", "type": "DRUG" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Umbilical Cord Blood Transplantation", "type": "BIOLOGICAL" }, { "name": "Interleukin-2", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "RADIATION", "BIOLOGICAL" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "2 Years to 45 Years" }, "enrollment_count": 3, "start_date": "2011-10", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2017-12-28", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01464359" }, { "nct_id": "NCT03949296", "title": "Mindfulness Meditation in Treating Insomnia in Multiple Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Insomnia Chronic", "Multiple Sclerosis" ], "interventions": [ { "name": "Mindfulness Intervention", "type": "BEHAVIORAL" }, { "name": "Sleep Hygiene", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Griffin Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2017-12-11", "completion_date": "2019-12-16", "has_results": false, "last_update_posted_date": "2020-02-26", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 1, "location_summary": "Derby, Connecticut", "locations": [ { "city": "Derby", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03949296" }, { "nct_id": "NCT00691015", "title": "Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Myeloproliferative Disorders", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms" ], "interventions": [ { "name": "rituximab", "type": "BIOLOGICAL" }, { "name": "busulfan", "type": "DRUG" }, { "name": "carmustine", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "fludarabine phosphate", "type": "DRUG" }, { "name": "melphalan", "type": "DRUG" }, { "name": "total body irradiation (TBI)", "type": "RADIATION" }, { "name": "anti-thymocyte globulin IV", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "RADIATION" ], "sponsor": "Barbara Ann Karmanos Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2008-05", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2017-06-28", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00691015" }, { "nct_id": "NCT02230891", "title": "Biomarker Guided Therapies in Stage A/B Heart Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertension", "Diabetes", "Cardiovascular Disease" ], "interventions": [ { "name": "Carvedilol", "type": "DRUG" }, { "name": "Spironolactone", "type": "DRUG" }, { "name": "Usual care", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 58, "start_date": "2014-10-01", "completion_date": "2020-12-15", "has_results": true, "last_update_posted_date": "2022-10-21", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02230891" }, { "nct_id": "NCT05794997", "title": "Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Propranolol or Carvedilol", "type": "DRUG" }, { "name": "Atenolol, Bisoprolol or Sotalol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 817337, "start_date": "2022-11-30", "completion_date": "2023-12-31", "has_results": true, "last_update_posted_date": "2025-11-10", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05794997" }, { "nct_id": "NCT01456208", "title": "Genetic Mechanisms in Human Hypertension", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Para-aminohippuric Acid", "type": "DRUG" }, { "name": "Angiotensin II", "type": "DRUG" }, { "name": "Norepinephrine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 150, "start_date": "1999-10", "completion_date": "2020-06", "has_results": false, "last_update_posted_date": "2021-05-12", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01456208" }, { "nct_id": "NCT00001417", "title": "Direct Injection of Alcohol for the Treatment of Spinal Tumors", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hemangioma", "Neoplasm Metastasis", "Spinal Neoplasm" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 30, "start_date": "1994-06", "completion_date": "2002-05", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001417" }, { "nct_id": "NCT00153478", "title": "Project CHOICES Efficacy Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Risk for an Alcohol-Exposed Pregnancy", "Hazardous Alcohol Use", "Risk for Unintended Pregnancy" ], "interventions": [ { "name": "Brief Motivational Counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "44 Years", "sex": "FEMALE", "summary": "18 Years to 44 Years · Female only" }, "enrollment_count": 1200, "start_date": "2002-07", "completion_date": "2004-08", "has_results": false, "last_update_posted_date": "2005-09-12", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 11, "location_summary": "Fort Lauderdale, Florida • Dayton, Texas • Houston, Texas + 1 more", "locations": [ { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Dayton", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00153478" }, { "nct_id": "NCT02016378", "title": "EEG/Event-related Brain Potential Risk Markers as Predictors and Outcomes of SUD Treatment in Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alcohol Use Disorder" ], "interventions": [ { "name": "Bias retraining", "type": "BEHAVIORAL" }, { "name": "Sham retraining", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "14 Years to 65 Years" }, "enrollment_count": 25, "start_date": "2014-01", "completion_date": "2022-12", "has_results": false, "last_update_posted_date": "2022-12-13", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02016378" }, { "nct_id": "NCT00273689", "title": "Exercise Induced Bronchospasm in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Exercise Induced Bronchospasm" ], "interventions": [ { "name": "montelukast vs pretreatment with albuterol", "type": "DRUG" }, { "name": "montelukast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "7 Years to 17 Years" }, "enrollment_count": 13, "start_date": "2005-12", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2008-05-07", "last_synced_at": "2026-10-17T22:49:44.457Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT00273689" } ] }